This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Alan Cameron - Innovator in Pharmaceutical Chemistry
Introduction
Alan Cameron is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.
Latest Patents
Alan Cameron holds a patent for "6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives." This patent includes novel compounds that exhibit excellent cysteine protease inhibitory activity. These compounds may be utilized in the treatment of various diseases, including muscular dystrophy, arthritis, myocardial infarction, Alzheimer's disease, bacterial infections, the common cold, osteoporosis, and cancer metastasis. He has 1 patent to his name.
Career Highlights
Alan is affiliated with the National Research Council of Canada, where he conducts research and development in pharmaceutical sciences. His work focuses on creating innovative solutions to complex health issues.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues such as Rajeshwar Singh and Jadwiga Kaleta. Their combined expertise has contributed to advancements in their respective fields.
Conclusion
Alan Cameron's innovative work in pharmaceutical chemistry highlights his commitment to improving health outcomes through research and development. His contributions are paving the way for new treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile